Szachniewicz, M., van den Eeden, S., van Meijgaarden, K., Franken, K., van Veen, S., Geluk, A., . . . Ottenhoff, T. (2025). Intradermal versus subcutaneous immunization: Effects of administration route using a lipid-PLGA hybrid nanoparticle tuberculosis vaccine. European journal of pharmaceutical sciences, 205, 106995. https://doi.org/10.1016/j.ejps.2024.106995
Chicago-Zitierstil (17. Ausg.)Szachniewicz, M.M, S.J.F van den Eeden, K.E van Meijgaarden, K.L.M.C Franken, S. van Veen, A. Geluk, J.A Bouwstra, und T.H.M Ottenhoff. "Intradermal Versus Subcutaneous Immunization: Effects of Administration Route Using a Lipid-PLGA Hybrid Nanoparticle Tuberculosis Vaccine." European Journal of Pharmaceutical Sciences 205 (2025): 106995. https://doi.org/10.1016/j.ejps.2024.106995.
MLA-Zitierstil (9. Ausg.)Szachniewicz, M.M, et al. "Intradermal Versus Subcutaneous Immunization: Effects of Administration Route Using a Lipid-PLGA Hybrid Nanoparticle Tuberculosis Vaccine." European Journal of Pharmaceutical Sciences, vol. 205, 2025, p. 106995, https://doi.org/10.1016/j.ejps.2024.106995.